The emergence of tumor metastases

被引:22
作者
Dingli, David
Michor, Franziska
Antal, Tibor
Pacheco, Jorge M.
机构
[1] Harvard Univ, Sch Med, Program Evolut Dynam, Cambridge, MA 02138 USA
[2] Mayo Clin, Coll Med, Div Hematol, Rochester, MI USA
[3] Harvard Soc Fellows, Cambridge, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Univ Lisbon, CFTC, Lisbon, Portugal
[6] Univ Lisbon, Dept Fis, Lisbon, Portugal
关键词
tumor; metastases; mathematical modeling; dynamics; evolution;
D O I
10.4161/cbt.6.3.3720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The appearance of metastases is an ominous sign in the natural history of any malignant tumor. Their presence implies a high tumor burden and greatly decreases the probability of a cure. Metastasis development requires the evolution of tumor cells that can survive in an environment that is normally not supportive to their growth and such cells must leave the tumor to establish tumor niches elsewhere. The interactions between the appearance of cells with metastatic ability in the primary tumor and their exit from the tumor lead to complex dynamics that can be either beneficial or detrimental to the tumor. We develop a simple mathematical model to illustrate how the interplay between mutation rate and export probability affects the intratumoral dynamics of metastasis enabled cells and the rate of metastases formation.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 54 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[3]  
ANTAL T, 2006, B MATH BIOL, V10
[4]   Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells [J].
Berger, JC ;
Vander Griend, D ;
Stadler, WM ;
Rinker-Schaeffer, C .
ANTI-CANCER DRUGS, 2004, 15 (06) :559-568
[5]   LATE METASTASES OF CUTANEOUS MELANOMA - CASE-REPORT AND LITERATURE-REVIEW [J].
BOI, S ;
AMICHETTI, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (02) :335-338
[6]   A pooled analysis of bone marrow micrometastasis in breast cancer [J].
Braun, S ;
Vogl, FD ;
Naume, B ;
Janni, W ;
Osborne, MP ;
Coombes, RC ;
Schlimok, G ;
Diel, IJ ;
Gerber, B ;
Gebauer, G ;
Pierga, JY ;
Marth, C ;
Oruzio, D ;
Wiedswang, G ;
Solomayer, EF ;
Kundt, G ;
Strobl, B ;
Fehm, T ;
Wong, GYC ;
Bliss, J ;
Vincent-Salomon, A ;
Pantel, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (08) :793-802
[7]   Unknown primary [J].
Chorost, MI ;
Lee, MC ;
Yeoh, CB ;
Molina, M ;
Ghosh, BC .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 87 (04) :191-203
[8]   Analysis of a "phase transition" from tumor growth to latency [J].
Delsanto, PP ;
Romano, A ;
Scalerandi, M ;
Pescarmona, GP .
PHYSICAL REVIEW E, 2000, 62 (02) :2547-2554
[9]   Proposal for a new model of breast cancer metastatic development [J].
Demicheli, R ;
Retsky, MW ;
Swartzendruber, DE ;
Bonadonna, G .
ANNALS OF ONCOLOGY, 1997, 8 (11) :1075-1080
[10]  
Frank SA, 2003, GENETICS, V163, P1527